project id: TCGA-SKCM; case submitter id: TCGA-HR-A2OH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.8; age at index: 46; days to birth: -16910; days to death: 2004; ethnicity: not reported; gender: female; race: not reported; vital status: Dead; age at diagnosis: 16910; ajcc pathologic m: M0; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C76.3; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Pelvis, NOS; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 370.0; portion submitter id: TCGA-HR-A2OH-06A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0;